Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 [Phase 3]

View source ↗

Summary

A Phase 3 study to evaluate the efficacy and safety of ALKS 2680 in adults with Narcolepsy Type 1; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy Type

Drugs mentioned

• ALKS 2680

Snippet

Sponsor: Alkermes, Inc. | Conditions: Narcolepsy Type 1 | Phase 3 | Status: RECRUITING